跳至主要内容
临床试验/NCT03541759
NCT03541759已完成4 期

Pain Management After Elective Shoulder Surgery: A Randomized Quantitative Study Comparing Hydromorphone With Piritramide

AUVA Traumazentrum Vienna Site UKH Meidling1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2018年1月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
48
试验地点
1
主要终点
Pain management after elective shoulder surgery

研究概览

简要总结

Postoperative pain management plays an important role in elective shoulder surgery. The aim of this randomized quantitative study is to compare two frequently used postoperative pain regimes (hydromorphone versus piritramide) regarding onset and duration after the effectiveness of the single-shot interscalene block has diminished.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all patients undergoing elective shoulder surgery with a single-shot interscalene plexus brachialis block in addition to general anesthesia
  • patients aged 18-99 years
  • patients being capable of giving an informed consent to participation in this study

排除标准

  • patients aged below 18 years
  • patients with decompensated liver, heart or renal insufficiency
  • patients with any kind of lung disease
  • patients with a chronic pain syndrome
  • patients with a previous pain medication with more than 3 drugs over more than 3 months

研究组 & 干预措施

Hydromorphone

Active Comparator

Hydromorphone Hcl 4 milligram (mg) Tab 2 times after surgery as basic medication. Hydromorphone Hcl 2.6mg maximum 2 per 24h when numeric rating scale (NRS) > 5.

干预措施: Hydromorphone Hcl 4Mg Tab (Drug)

Piritramide

Active Comparator

Piritramide 15mg s.c. 2 times after surgery as basic medication. Piritramide 7.5mg s.c. maximum 2 per 24h when numeric rating scale (NRS) > 5.

干预措施: Piritramide 15mg s.c. (Drug)

结局指标

主要结局

Pain management after elective shoulder surgery

时间窗: 6 months

Comparison of hydromorphone versus piritramide using the numeric rating scale (NRS; range 0 - 10 points; level 0 representing no pain; level 10 representing the highest pain level)

次要结局

未报告次要终点

研究者

发起方
AUVA Traumazentrum Vienna Site UKH Meidling
申办方类型
Other
责任方
Principal Investigator
主要研究者

Sandra Boesmueller, MD, PhD

Principal Investigator

AUVA Traumazentrum Vienna Site UKH Meidling

研究点 (1)

Loading locations...

相似试验

Pain Management After Elective Shoulder Surgery | 临床试验